BACKGROUND: There is a lack of effective behavioral interventions for HIV-positive injection drug users (IDUs). We sought to evaluate the efficacy of an intervention to reduce sexual and injection transmission risk behaviors and to increase utilization of medical care and adherence to HIV medications among this population. METHODS:HIV-positive IDUs (n=966) recruited in 4 US cities were randomly assigned to a 10-session peer mentoring intervention or to an 8-session video discussion intervention (control condition). Participants completed audio computer-assisted self-interviews and had their blood drawn to measure CD4 cell count and viral load at baseline and at 3-month (no blood), 6-month, and 12-month follow-ups. RESULTS:Overall retention rates for randomized participants were 87%, 83%, and 85% at 3, 6, and 12 months, respectively. Participants in both conditions reported significant reductions from baseline in injection and sexual transmission risk behaviors, but there were no significant differences between conditions. Participants in both conditions reported no change in medical care and adherence, and there were no significant differences between conditions. CONCLUSIONS: Both interventions led to decreases in risk behaviors but no changes in medical outcomes. The characteristics of the trial that may have contributed to these results are examined, and directions for future research are identified.
RCT Entities:
BACKGROUND: There is a lack of effective behavioral interventions for HIV-positive injection drug users (IDUs). We sought to evaluate the efficacy of an intervention to reduce sexual and injection transmission risk behaviors and to increase utilization of medical care and adherence to HIV medications among this population. METHODS: HIV-positive IDUs (n=966) recruited in 4 US cities were randomly assigned to a 10-session peer mentoring intervention or to an 8-session video discussion intervention (control condition). Participants completed audio computer-assisted self-interviews and had their blood drawn to measure CD4 cell count and viral load at baseline and at 3-month (no blood), 6-month, and 12-month follow-ups. RESULTS: Overall retention rates for randomized participants were 87%, 83%, and 85% at 3, 6, and 12 months, respectively. Participants in both conditions reported significant reductions from baseline in injection and sexual transmission risk behaviors, but there were no significant differences between conditions. Participants in both conditions reported no change in medical care and adherence, and there were no significant differences between conditions. CONCLUSIONS: Both interventions led to decreases in risk behaviors but no changes in medical outcomes. The characteristics of the trial that may have contributed to these results are examined, and directions for future research are identified.
Authors: Yuko Mizuno; David W Purcell; Lisa R Metsch; Cynthia A Gomez; Amy R Knowlton; Mary H Latka Journal: J Urban Health Date: 2011-12 Impact factor: 3.671
Authors: Nicole Crepaz; Malu V Tungol-Ashmon; Darrel H Higa; Waverly Vosburgh; Mary M Mullins; Terrika Barham; Adebukola Adegbite; Julia B DeLuca; Theresa A Sipe; Christina M White; Brittney N Baack; Cynthia M Lyles Journal: AIDS Date: 2014-03-13 Impact factor: 4.177
Authors: Sarah Pollock; Forrest Toegel; August F Holtyn; Andrew M Rodewald; Jeannie-Marie Leoutsakos; Michael Fingerhood; Kenneth Silverman Journal: Drug Alcohol Depend Date: 2020-04-25 Impact factor: 4.492
Authors: Carl A Latkin; Deborah Donnell; David Metzger; Susan Sherman; Apinun Aramrattna; Annet Davis-Vogel; Vu Minh Quan; Sharavi Gandham; Tasanai Vongchak; Tom Perdue; David D Celentano Journal: Soc Sci Med Date: 2008-12-13 Impact factor: 4.634
Authors: Mahnaz R Charania; Khiya J Marshall; Cynthia M Lyles; Nicole Crepaz; Linda S Kay; Linda J Koenig; Paul J Weidle; David W Purcell Journal: AIDS Behav Date: 2014-04
Authors: Adrian Liau; Nicole Crepaz; Cynthia M Lyles; Darrel H Higa; Mary M Mullins; Julia DeLuca; Sarah Petters; Gary Marks Journal: AIDS Behav Date: 2013-07
Authors: Susan G Sherman; Catherine Sutcliffe; Bangorn Srirojn; Carl A Latkin; Apinun Aramratanna; David D Celentano Journal: Soc Sci Med Date: 2008-11-03 Impact factor: 4.634
Authors: Carl A Latkin; Amy S Buchanan; Lisa R Metsch; Kelly Knight; Mary H Latka; Yuko Mizuno; Amy R Knowlton Journal: J Acquir Immune Defic Syndr Date: 2008-12-01 Impact factor: 3.731